SecurityAP / Ampco-Pittsburgh Corp. (032037103)
Institutional Owners91 (27 N-Q Owners)
Institutional Shares8,272,643 - 66.92% (ex. N-Q)
Common Shares Outstanding12,362,198 shares (as of 2017-12-31)
Institutional Value$ 585,620,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Ampco-Pittsburgh Corp. (NYSE:AP) has 91 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8,272,643 shares. Largest shareholders include Gamco Investors, Inc. Et Al, Louis Berkman Investment Co, Dimensional Fund Advisors Lp, BlackRock Inc., Gabelli Funds Llc, Vanguard Group Inc, Teton Advisors, Inc., QV Investors Inc., Walthausen & Co., LLC, and Renaissance Technologies LLC.

Ampco-Pittsburgh Corp. (NYSE:AP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-13 13F-HR Parisi Gray Wealth Management 1,325 17
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 15,237 0 -100.00 265 0 -100.00
2017-12-13 N-Q Walthausen Funds (see advisory)
2018-02-15 13F-HR Fieldpoint Private Securities, LLC 966 0 -100.00 17 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 12,576 0 -100.00 185 0 -100.00
2018-02-28 N-Q Ishares Trust (see advisory)
2018-01-31 13F-HR WEDGE CAPITAL MANAGEMENT L L P/NC 48,300 48,300 0.00 840 599 -28.69
2018-01-23 13F-HR QV Investors Inc. 337,445 322,875 -4.32 5,871 4,003 -31.82
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 1,344 17
2018-02-13 13F-HR JP Morgan Chase & Co 0 1,882 0 23
2018-02-14 13F-HR MACQUARIE GROUP LTD 7,612 2,973 -60.94 132 37 -71.97
2018-02-14 13F-HR/A-1 Boston Partners 207,062 106,140 -48.74 3,603 1,316 -63.47
2018-02-14 13F-HR PEAK6 Investments, L.P. Put 500 0 -100.00 9 0 -100.00
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 907 2,607 187.43 15,782 32,327 104.83
2017-11-29 N-Q Gabelli Global Utility & Income Trust (see advisory)
2018-02-02 13F-HR US BANCORP \DE\ 23,379 23,768 1.66 407 295 -27.52
2017-11-22 N-Q Bridgeway Funds Inc (see advisory)
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 23,042 24,141 4.77 401 299 -25.44
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 5,831 5,859 0.48 101 73 -27.72
2018-02-09 13F-HR Bank of New York Mellon Corp 98,437 98,026 -0.42 1,713 1,215 -29.07
2018-02-28 N-Q Rydex Dynamic Funds (see advisory)
2017-11-29 N-Q Gamco Global Series Funds, Inc (see advisory)
2018-02-12 13F-HR Adirondack Research & Management Inc. 58,755 83,141 41.50 1,022 1,031 0.88
2018-02-16 13F-HR SALEM INVESTMENT COUNSELORS INC 0 25 0 0
2018-02-28 13F-HR/A-1 FEDERATED INVESTORS INC /PA/ 293 52,495 17,816.38 5 651 12,920.00
2018-02-13 13F-HR Legal & General Group Plc 1,324 1,324 0.00 23 16 -30.43
2018-02-09 13F-HR RHUMBLINE ADVISERS 10,166 0 -100.00 177 0 -100.00
2017-11-29 N-Q Gabelli Investor Funds Inc (see advisory)
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2018-04-10 SC 13D/A Louis Berkman Investment Co 1,312,929
2018-02-13 13F-HR MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 41,259 38,375 -6.99 710 475,850 66,921.13
2018-02-14 13F-HR ROYAL BANK OF CANADA 5,875 3,061 -47.90 102 38 -62.75
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-14 13F-HR DEUTSCHE BANK AG\ 9,021 19,599 117.26 156 242 55.13
2018-02-14 13F-HR RBF Capital, LLC 50,656 50,656 0.00 881 628 -28.72
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 8,262 9,329 12.91 143 116 -18.88
2018-02-28 N-Q Rydex Series Funds (see advisory)
2018-02-13 13F-HR ClariVest Asset Management LLC 12,638 15,399 21.85 220 191 -13.18
2018-01-22 13F-HR Founders Capital Management 1,000 0 -100.00 17 0 -100.00
2017-10-27 N-Q Stone Ridge Trust (see advisory)
2018-02-27 N-Q GABELLI EQUITY SERIES FUNDS INC (see advisory)
2018-01-17 13F-HR Cutler Group LP 600 298 -50.33 10 3 -70.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 200 2
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 1,384 3,539 155.71 24 44 83.33
2017-11-07 13F-HR AMERIPRISE FINANCIAL INC 13,898 0 -100.00 205 0 -100.00
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 18,900 18,900 0.00 329 235 -28.57
2018-02-14 13F-HR Walthausen & Co., LLC 316,664 289,780 -8.49 5,510 3,593 -34.79
2018-02-09 13F-HR Royce & Associates LLC 254,580 249,830 -1.87 4,430 3,098 -30.07
2018-02-05 13F-HR QCI ASSET MANAGEMENT INC/NY 4,240 0 -100.00 74 0 -100.00
2017-11-29 N-Q Gabelli Capital Series Funds Inc (see advisory)
2018-02-14 13F-HR BARCLAYS PLC 660 1,733 162.58 12 21 75.00
2017-11-14 13F-HR PEAK6 Investments, L.P. Call 20,100 0 -100.00 296 0 -100.00
2017-11-28 N-Q Putnam Variable Trust (see advisory)
2017-11-29 N-Q Gabelli Equity Trust Inc (see advisory)
2018-02-14 13F-HR Ancora Advisors, LLC 66,436 0 -100.00 1,156 0 -100.00
2018-02-14 13F-HR Clearbridge Investments, LLC 1,600 1,600 0.00 28 20 -28.57
2018-02-14 13F-HR PEAK6 Investments, L.P. 11,454 0 -100.00 199 0 -100.00
2017-12-14 13F-HR/A-1 PARAMETRIC PORTFOLIO ASSOCIATES LLC 16,643 0 -100.00 234 0 -100.00
2018-02-02 13F-HR GABELLI FUNDS LLC 531,008 528,008 -0.56 9,240 6,547 -29.15
2018-02-14 13F-HR VANGUARD GROUP INC 475,645 476,783 0.24 8,276 5,912 -28.56
2018-02-14 13F-HR TEACHERS ADVISORS INC 17,770 17,087 -3.84 309 212 -31.39
2018-02-07 13F-HR Cranbrook Wealth Management, LLC 473 473 0.00 8 6 -25.00
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 28,608 19,621 -31.41 498 243 -51.20
2018-02-14 13F-HR Brandywine Global Investment Management, LLC 0 7,349 0 92
2018-02-14 13F-HR FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 135,000 135,000 0.00 2,349 1,674 -28.74
2018-01-26 N-Q Trust For Professional Managers (see advisory)
2018-02-13 13F-HR Delpha Capital Management, Llc 230 3
2018-02-27 N-Q Northern Funds (see advisory)
2018-02-14 13F-HR QUANTUM CAPITAL MANAGEMENT 65,712 80,795 22.95 1,143 1,002 -12.34
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 667 667 0.00 10 8 -20.00
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 9,407 2,187 -76.75 164 27 -83.54
2018-01-17 13F-HR Cutler Group LP Call 1,100 0 -100.00 0 0
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-02-09 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 2,500 2,500 0.00 44 31 -29.55
2018-02-14 13F-HR Invesco Ltd. 22,553 19,650 -12.87 392 244 -37.76
2018-02-14 13F-HR STATE STREET CORP 129,358 133,778 3.42 2,251 1,659 -26.30
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2018-02-14 13F-HR/A-1 PUTNAM INVESTMENTS LLC 56,844 0 -100.00 989 0 -100.00
2017-11-29 N-Q Gabelli Value 25 Fund Inc (see advisory)
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 8,800 8,800 0.00 153 109 -28.76
2017-11-29 N-Q Gabelli Global Small & Mid Cap Value Trust (see advisory)
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 6,286 14,950 137.83 109 185 69.72
2017-11-29 N-Q Gabelli Go Anywhere Trust (see advisory)
2018-02-23 N-Q Rbc Funds Trust (see advisory)
2018-02-09 13F-HR BlackRock Inc. 584,347 600,154 2.71 10,168 7,442 -26.81
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 14,252 13,852 -2.81 248 172 -30.65
2018-02-12 13F-HR CITIGROUP INC 1,600 2,888 80.50 28 36 28.57
2018-02-13 13F-HR FIRST INTERSTATE BANK 600 0 -100.00 10 0 -100.00
2018-02-02 13F-HR GAMCO INVESTORS, INC. ET AL 1,499,769 1,428,329 -4.76 26,096 17,711 -32.13
2018-02-14 13F-HR MORGAN STANLEY 17,701 25,328 43.09 308 314 1.95
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 66,804 67,981 1.76 1,162 842 -27.54
2018-02-14 13F-HR NORTHERN TRUST CORP 104,283 104,285 0.00 1,815 1,293 -28.76
2018-02-13 13F-HR Renaissance Technologies LLC 264,500 271,200 2.53 4,602 3,363 -26.92
2018-02-02 13F-HR Teton Advisors, Inc. 470,000 471,844 0.39 8,178 5,851 -28.45
2018-02-14 13F-HR UBS Group AG 2,423 927 -61.74 42 11 -73.81
2018-02-27 N-Q TETON WESTWOOD FUNDS (see advisory)
2018-02-14 13F-HR 22NW, LP 46,175 70,672 53.05 803 876 9.09
2017-11-28 N-Q Ancora Trust (see advisory)
2017-11-20 13F-HR/A-1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 15,600 271
2018-02-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 77,399 77,399 0.00 1,347 960 -28.73
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 42,000 42,000 0.00 731 521 -28.73
2018-03-01 N-Q Mutual Fund Series Trust (see advisory)
2018-02-16 13F-HR/A-1 Commonwealth Equity Services, Inc 19,891 0 -100.00 293 0 -100.00
2018-02-09 SC 13G DIMENSIONAL FUND ADVISORS LP 673,086
2017-11-28 N-Q Usaa Mutual Funds Trust (see advisory)
2018-02-14 13F-HR MENTA CAPITAL LLC 21,650 18,717 -13.55 377 232 -38.46
2018-02-01 13F-HR Nationwide Fund Advisors 15,925 0 -100.00 277 0 -100.00
2018-02-14 13F-HR PHILADELPHIA TRUST CO 162,275 164,650 1.46 2,824 2,042 -27.69

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( AP / Ampco-Pittsburgh Corp. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 032037103